Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cataplexy”

61 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 61 results

Early research (Phase 1)Study completedNCT00345800
What this trial is testing

Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes

Who this might be right for
Narcolepsy With Cataplexy
UCB Pharma SA 25
Large-scale testing (Phase 3)Study completedNCT05113745
What this trial is testing

Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE)

Who this might be right for
NarcolepsyCataplexyExcessive Daytime Sleepiness
Axsome Therapeutics, Inc. 68
Early research (Phase 1)Study completedNCT01093508
What this trial is testing

Single-dose Safety Study of APD916 in Healthy Volunteers

Who this might be right for
Narcolepsy With or Without Cataplexy
Arena Pharmaceuticals 72
Testing effectiveness (Phase 2)Study completedNCT03772314
What this trial is testing

Modafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic Hypersomnia

Who this might be right for
Idiopathic HypersomniaNarcolepsy Without Cataplexy
Emory University 44
Not applicableStudy completedNCT00174174
What this trial is testing

Provigil (Modafinil) Study by Taiwan Biotech Co.

Who this might be right for
NarcolepsyCataplexySleep Disorders+2 more
National Taiwan University Hospital 30
Testing effectiveness (Phase 2)Study completedNCT05055024
What this trial is testing

An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy

Who this might be right for
Narcolepsy With CataplexyNarcolepsyNarcolepsy Without Cataplexy
NLS Pharmaceutics 52
Not applicableStudy completedNCT05615584
What this trial is testing

Spectrometry (MRM) Versus I 125 Radioimmunoassay (RIA) for Quantification of Orexin-A of Patients With Hypersomnolence

Who this might be right for
NarcolepsyIdiopathic HypersomniaCataplexy
University Hospital, Montpellier 117
Not applicableStudy completedNCT02913651
What this trial is testing

Cardiovascular Variability and Heart Rate Arousal Response in Idiopathic Hypersomnia

Who this might be right for
NarcolepsyCataplexy
Centre Hospitalier Universitaire de Saint Etienne 33
Testing effectiveness (Phase 2)Study completedNCT05687903
What this trial is testing

TAK-861 in Participants With Narcolepsy Type 1

Who this might be right for
Narcolepsy Type 1
Takeda 112
Large-scale testing (Phase 3)Study completedNCT01067235
What this trial is testing

Efficacy and Safety Study of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With Narcolespy

Who this might be right for
NarcolepsyCataplexyExcessive Daytime Sleepiness
Bioprojet 14
Not applicableLooking for participantsNCT06383806
What this trial is testing

Decreasing Nightmares in Adults With Narcolepsy

Who this might be right for
NarcolepsyNarcolepsy Type 1Narcolepsy With Cataplexy+3 more
University of Utah 80
Testing effectiveness (Phase 2)Looking for participantsNCT07633301
What this trial is testing

TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)

Who this might be right for
Narcolepsy Type 1
Takeda 92
Large-scale testing (Phase 3)Study completedNCT06470828
What this trial is testing

TAK-861 for the Treatment of Narcolepsy Type 1

Who this might be right for
Narcolepsy Type 1
Takeda 168
Large-scale testing (Phase 3)Study completedNCT01638403
What this trial is testing

Effects of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy.

Who this might be right for
Treatment of Excessive Daytime Sleepiness in Narcolepsy
Bioprojet 180
Testing effectiveness (Phase 2)Ended earlyNCT04820842
What this trial is testing

TAK-994 in Adults With Narcolepsy

Who this might be right for
Narcolepsy Type 1 (NT 1)
Takeda 26
Testing effectiveness (Phase 2)Study completedNCT04026958
What this trial is testing

Clarithromycin Mechanisms in Hypersomnia Syndromes

Who this might be right for
Narcolepsy Without CataplexyIdiopathic HypersomniaNarcolepsy With Cataplexy
Emory University 83
Large-scale testing (Phase 3)Active Not RecruitingNCT07363720
What this trial is testing

A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy

Who this might be right for
Narcolepsy Type 1 (NT1)Narcolepsy With Cataplexy
Takeda 98
Large-scale testing (Phase 3)Study completedNCT02221869
What this trial is testing

Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy

Who this might be right for
Narcolepsy With Cataplexy
Jazz Pharmaceuticals 106
Testing effectiveness (Phase 2)Study completedNCT02512588
What this trial is testing

Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2

Who this might be right for
Idiopathic HypersomniaNarcolepsy Without Cataplexy
Balance Therapeutics 120
Large-scale testing (Phase 3)Looking for participantsNCT07455383
What this trial is testing

Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

Who this might be right for
Narcolepsy Type 1
Alkermes, Inc. 150
Next Page